Tiger Shark Kills American Tourist Diving Off Costa Rican Coast
December 4, 2017 by admin
Filed under Choosing Lingerie
Comments Off
An American tourist was killed by a tiger shark while diving off a Costa Rican island in the Pacific Ocean earlier this week.
The 49-year-old woman was identified by friends as Rohina Bhandari, a private equity director from New York City.
Local news reports from Costa Rica cited a statement from the Ministry of Environment and Energy saying Bhandari was hauled out of the water after sustaining severe bites to her legs after she was attacked by the shark while scuba diving off of remote Isla del Coco Thursday.
She was with a group of friends when the shark attacked as the group surfaced following a dive. The trip to the island of the Pacific ocean was organized by a private company. The diving instructor was also reportedly seriously injured but was said to be in a stable condition. The woman had suffered severe lacerations on both of her legs.
The 26-year-old diving guide identified by his last name Jimenez said it was a female tiger shark that attacked and killed Bhandari. He also said he tried to scare off the animal after noticing it first approach them. A boater and other divers also made attempts to drive the creature away but it was too late. “ Upon reaching the surface, the attack on the tourist was already serious, ” the ministry said., according to Q Costa Rica News.
Authorities said two park rangers of the Sistema Nacional de Áreas de Conservación (SINAC) and several doctors who were part of the diving tourism group of 18 people on the island trip by Undersea Hunter Group offered first aid. The group regularly organized tours to the national park, which is a Natural World Heritage Site reportedly known for its abundance of sharks. The environment ministry, meanwhile, stressed that attack was ‘an isolated incident’ and the first one of such seriousness recorded for the island.
Alan Steenstrup, the tour company’s sales manager, said they were “in shock” because of the incident and added they were now focusing on working with the victim’s family and the authorities.
According to New York Daily News, Bhandari was a resident of Manhattan’s Upper East Side and a senior director at WL Ross Co. LL, a firm founded by Commerce Secretary Wilbur Ross. She was also frequently seen at charity events throughout the city.
It was reported that the boat carrying Bhandari’s body would arrive at the Puerto Caldera after traveling the 532 kilometers from the island on Friday night. It would then will be transferred to the Forensic Medicine Laboratory in Heredia before being repatriated. However, it is not known where the body had been taken as of Sunday morning.
Bhandari’s friends reacted with shock and sadness on her Facebook page upon learning the news of her death.
“Rohina you were the brightest of lights that went out much too soon,” one person wrote. “My life was richer for having known you.”
“Unbelievably sad and heartbreaking news that Rohina has died,” another said. “She was such a wonderful person who loved life. I will always remember her kindness, friendship, and our adventures together.”
Share and Enjoy
CVS to Buy Aetna for $69 Billion in a Deal That May Reshape the Health Industry
December 4, 2017 by admin
Filed under Lingerie Events
Comments Off
On Sunday, the two companies emphasized their ability to transform CVS’s 10,000 pharmacy and clinic locations into community-based sites of care that would be far less expensive for patients.
“We think of it as creating a new front door to health care in America,” CVS Health’s chief executive, Larry J. Merlo, said in an interview.
The merger would establish a new way of delivering care, with nurses, pharmacists and others available to counsel people about their diabetes or do the lab work necessary to diagnose a condition, Mr. Merlo said. “We know we can make health care more affordable and less expensive.”
Mark T. Bertolini, Aetna’s chief executive, said that by using CVS’s locations, the company can provide people with a better way of accessing medical care.
Credit
Mario Anzuoni/Reuters
“It’s in their community. It’s in their home,” he said. He added, “CVS has the draw. People trust their pharmacist.”
It is the development of community-based clinics — capable of delivering care with the technology and health information available from both parties — that could prove to be the biggest change brought about the deal.
The hope would be that consumers would not only be able to see savings by going to a retail store to treat a sore throat but also have better oversight of a chronic illness, such as diabetes or heart disease. They could get advice on how to lose weight, or undergo tests to monitor their health.
Advertisement
Continue reading the main story
“If they can drive the adoption of the care delivery model, that’s a big deal,” said Ana Gupte, a senior health care analyst for Leerink Partners.
The merger agreement came as another factor weighs on the minds of all in the health care industry: Amazon, which has been rumored to be preparing for an entry into the pharmacy business. Jeff Bezos, the Amazon chief executive, and his e-commerce juggernaut have already overturned many industries: book buying, retail shopping, groceries and Hollywood, using fierce customer loyalty and enormous reach as cudgels against incumbent players.
But CVS and Aetna have had a business partnership dating back seven years, and have steadily converged into similar visions of how the health care industry was evolving. Conversations about a deeper bond eventually crystallized into deal talks within the last two months, according to a person with direct knowledge of the discussions.
Although neither chief executive mentioned Amazon by name, both said that what they were creating was a compelling opportunity in and of itself.
Newsletter Sign Up
Continue reading the main story
Thank you for subscribing.
An error has occurred. Please try again later.
You are already subscribed to this email.
“Chasing our competitors has never been a solution,” Mr. Bertolini said. He added, “Our competitors will do what they do.”
Many companies are seeking shelter in the arms of their former adversaries, with well-known medical groups like the Cleveland Clinic joining with Oscar Health, an insurer. With federal officials blocking traditional mergers — like the megadeal that featured Anthem and Cigna, the nation’s largest insurers, and one involving Aetna and its rival Humana — companies are looking at combinations that take them beyond their traditional lines of business.
Many analysts view the combination of CVS and Aetna as a defensive move by the companies. CVS Health, which also recently signed an agreement with Anthem to help the insurer start its own internal pharmacy benefit manager, is looking to protect its business with Aetna as it fends off rivals like UnitedHealth Group’s OptumRx and others. Aetna, foiled in its attempt to buy Humana, is searching for new ways to expand its business.
Credit
Bill Sikes/Associated Press
The merger could also fundamentally reshape the business of overseeing drug coverage for insurers, an industry that is dominated by three large players and that has increasingly come under scrutiny over the past year as public anger over high drug prices has expanded beyond the usual culprits — most notably the pharmaceutical industry — to lesser-known players like pharmacy benefit managers.
Under the terms of the deal, CVS will pay about $207 a share, based on Friday’s closing prices. Roughly $145 a share of that would be in cash, with the remainder in newly issued CVS stock. The deal is expected to close in the second half of next year, subject to approval by shareholders of both companies as well as regulators.
Advertisement
Continue reading the main story
Antitrust approval has become an interesting question in the Trump administration, which bankers and lawyers had thought would be more tolerant of consolidation than its predecessor.
A combination of a drugstore company and an insurer is considered less problematic than a merger of two players in the same business, which could reduce competition and hurt consumers. Such concerns ultimately sank Aetna’s efforts to buy Humana, and Anthem’s push to buy Cigna, when the Obama administration signaled its opposition to such consolidation.
CVS’s proposed takeover of Aetna is a so-called vertical merger, combining companies in two different industries. But while such deals have traditionally met little opposition in Washington, the Justice Department has sued to block ATT’s $85.4 billion takeover of Time Warner on the grounds that it would create too powerful of a content company.
Both CVS and Aetna played down the prospects of regulators moving to block their deal. The breakup fee for the transaction is not especially large, reflecting that belief.
Mr. Bertolini asserted that the companies would not raise prices for consumers. “It doesn’t make sense for us to charge people more when we want more people in the store,” he said.
But analysts and other merger experts warn that the deal could be blocked by federal antitrust officials who worry that it could lessen competition. One area of focus may be Medicare; both companies are significant players in offering prescription drug plans to Medicare beneficiaries.
While the companies said they want to lower costs, CVS also makes money on rebates from drug makers and on filling prescriptions through its pharmacies.
David A. Balto, an antitrust lawyer who has been sharply critical of combinations among insurers and pharmacy benefit managers, said that he was wary of having retailers in charge of people’s health. He argued that doctors may be in a better position to treat illness than retail executives.
“Who do you want to run the health care system?” he said.
Continue reading the main story